{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T03:40:26Z","timestamp":1769744426058,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ijantimicag.2023.106745","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T18:36:09Z","timestamp":1675881369000},"page":"106745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["National surveillance of antimicrobial susceptibilities to ceftaroline, dalbavancin, telavancin, tedizolid, eravacycline, omadacycline, and other comparator antibiotics, and genetic characteristics of bacteremic Staphylococcus aureus isolates in adults: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) program in 2020"],"prefix":"10.1016","volume":"61","author":[{"given":"Chih-Hao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pin-Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Chi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Wang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2023.106745_bib0001","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0002","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-1-62703-664-1_8","article-title":"Staphylococcal Cassette Chromosome mec (SCCmec) analysis of MRSA","volume":"1085","author":"Ito","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0003","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/labinvest.3700501","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin","volume":"87","author":"Boyle-Vavra","year":"2007","journal-title":"Lab Invest"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0004","doi-asserted-by":"crossref","first-page":"18033","DOI":"10.1038\/nrdp.2018.33","article-title":"Methicillin-resistant Staphylococcus aureus","volume":"4","author":"Lee","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0005","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/cid\/cir147","article-title":"Ceftaroline: a novel cephalosporin with activity against methicillin-resistant Staphylococcus aureus","volume":"52","author":"Saravolatz","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0006","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.1016\/j.bmc.2016.05.052","article-title":"The action mechanism of daptomycin","volume":"24","author":"Taylor","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0007","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/cid\/ciu971","article-title":"Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureus","volume":"60","author":"Corey","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0008","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/526772","article-title":"Dalbavancin: a novel once-weekly lipoglycopeptide antibiotic","volume":"46","author":"Billeter","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0009","first-page":"e01715","article-title":"In vitro activity of eravacycline against Gram-positive bacteria isolated in clinical laboratories worldwide from 2013 to 2017","volume":"64","author":"Morrissey","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02262-18","article-title":"Antimicrobial activity of omadacycline tested against clinical bacterial isolates from hospitals in mainland China, Hong Kong, and Taiwan: Results from the SENTRY Antimicrobial Surveillance Program (2013 to 2016)","volume":"63","author":"Carvalhaes","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0011","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/AAC.04052-14","article-title":"Baseline activity of telavancin against Gram-positive clinical isolates responsible for documented infections in U.S. hospitals (2011-2012) as determined by the revised susceptibility testing method","volume":"59","author":"Mendes","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0012","series-title":"CLSI Performance Standards for Antimicrobial Susceptibility Testing","year":"2022"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0013","unstructured":"EUCAST Breakpoint Tables for Interpretation of MICs and Zone Diameters, Version 10.0. European Committee on Antimicrobial Susceptibility Testing. available from: https:\/\/www.eucast.org\/ast_of_bacteria\/previous_versions_of_documents. Accessed: 17 Jan, 2023."},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0014","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1128\/AAC.45.7.1955-1963.2001","article-title":"Genetic organization of the chromosome region surrounding mecA in clinical staphylococcal strains: role of IS431-mediated mecI deletion in expression of resistance in mecA-carrying, low-level methicillin-resistant Staphylococcus haemolyticus","volume":"45","author":"Katayama","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0015","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1128\/JCM.43.10.5026-5033.2005","article-title":"Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus","volume":"43","author":"Zhang","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0016","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1128\/AAC.48.7.2637-2651.2004","article-title":"Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC","volume":"48","author":"Ito","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0017","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/AAC.00165-06","article-title":"Combination of multiplex PCRs for staphylococcal cassette chromosome mec type assignment: rapid identification system for mec, ccr, and major differences in junkyard regions","volume":"51","author":"Kondo","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0018","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jac\/dki471","article-title":"Molecular characterization of methicillin-resistant Staphylococcus aureus strains from pet animals and their relationship to human isolates","volume":"57","author":"Strommenger","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0019","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jmii.2020.04.017","article-title":"In vitro susceptibility of ceftaroline against clinically important Gram-positive cocci, Haemophilus species and Klebsiella pneumoniae in Taiwan: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018","volume":"54","author":"Jean","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0020","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1093\/jac\/dkv131","article-title":"Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline","volume":"70","author":"Lahiri","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0021","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jmii.2021.09.003","article-title":"Molecular epidemiology and phenotypes of invasive methicillin-resistant vancomycin-intermediate Staphylococcus aureus in Taiwan","volume":"55","author":"Wang","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0022","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/jac\/dkr169","article-title":"Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia","volume":"66","author":"Khatib","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0023","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/cid\/cis492","article-title":"In vitro susceptibilities and molecular analysis of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus isolates","volume":"55","author":"Saravolatz","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0024","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1128\/AAC.00742-09","article-title":"Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies","volume":"53","author":"Kosowska-Shick","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0025","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1089\/mdr.2019.0104","article-title":"Antimicrobial activity of telavancin tested in vitro against a global collection of Gram-Positive pathogens, including multidrug-resistant isolates (2015-2017)","volume":"26","author":"Duncan","year":"2020","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0026","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s40801-020-00191-x","article-title":"Clinical experience with telavancin for the treatment of patients with bacteremia and endocarditis: Real-world results from the Telavancin Observational Use Registry (TOUR)","volume":"7","author":"Reilly","year":"2020","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0027","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jgar.2017.03.018","article-title":"Telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2014)","volume":"10","author":"Duncan","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0028","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.diagmicrobio.2010.10.031","article-title":"Canadian Antimicrobial Resistance A. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study","volume":"69","author":"Karlowsky","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0029","article-title":"In vitro activity of dalbavancin against refractory multidrug-resistant (MDR) Staphylococcus aureus isolates","volume":"9","author":"Bongiorno","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0030","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/1120009X.2019.1609740","article-title":"Activity of tedizolid against gram-positive clinical isolates causing infections in Europe and surrounding areas (2014-2015)","volume":"31","author":"Pfaller","year":"2019","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0031","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/jac\/dkaa422","article-title":"Identification of a novel tedizolid resistance mutation in rpoB of MRSA after in vitro serial passage","volume":"76","author":"Shen","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0032","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/jac\/dkt366","article-title":"High genetic diversity of methicillin-susceptible Staphylococcus aureus (MSSA) from humans and animals on livestock farms and presence of SCCmec remnant DNA in MSSA CC398","volume":"69","author":"Vandendriessche","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0033","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1038\/s41598-021-83578-2","article-title":"Association between fluoroquinolone resistance and MRSA genotype in Alexandria","volume":"11","author":"Alseqely","year":"2021","journal-title":"Egypt. Sci Rep"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0034","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1128\/AAC.00315-11","article-title":"Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009","volume":"55","author":"Richter","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0035","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/JCM.43.9.4719-4730.2005","article-title":"Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel Staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV","volume":"43","author":"Boyle-Vavra","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0036","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jfma.2012.05.012","article-title":"Epidemiology and staphylococcal cassette chromosome mec typing of methicillin-resistant Staphylococcus aureus isolates in Taiwan: A multicenter study","volume":"113","author":"Pan","year":"2014","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0037","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/512627","article-title":"Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus","volume":"28","author":"Shurland","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0038","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jmii.2018.12.016","article-title":"Prevalence and molecular characteristics of MRSA nasal carriage among hospital care workers in a tertiary hospital in the Philippines","volume":"53","author":"Buenaventura-Alcazaren","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0039","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jmii.2018.12.014","article-title":"High incidence of acquiring methicillin-resistant Staphylococcus aureus in Brazilian children with Atopic Dermatitis and associated risk factors","volume":"53","author":"Abad","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106745_bib0040","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jmii.2020.07.021","article-title":"Current status of oxacillin-susceptible mecA-positive Staphylococcus aureus infection in Shanghai, China: A multicenter study","volume":"54","author":"Liu","year":"2021","journal-title":"J Microbiol Immunol Infect"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485792300033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485792300033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:45:15Z","timestamp":1760377515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485792300033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S092485792300033X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106745","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"National surveillance of antimicrobial susceptibilities to ceftaroline, dalbavancin, telavancin, tedizolid, eravacycline, omadacycline, and other comparator antibiotics, and genetic characteristics of bacteremic Staphylococcus aureus isolates in adults: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) program in 2020","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106745"}}